Filing Details
- Accession Number:
- 0001628280-25-005686
- Form Type:
- 13D Filing
- Publication Date:
- 2025-02-13 19:00:00
- Filed By:
- Reshma P. Shetty
- Company:
- Ginkgo Bioworks Holdings Inc.
- Filing Date:
- 2025-02-14
- SEC Url:
- 13D Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Reshma P. Shetty | 0 | 4,716,084 | 0 | 4,716,084 | 4,716,084 | 9.5% |
| Barry Canton | 0 | 4,716,084 | 0 | 4,716,084 | 4,716,084 | 9.5% |
Filing
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 4)
|
Ginkgo Bioworks Holdings, Inc. (Name of Issuer) |
Class A Common Stock (Title of Class of Securities) |
37611X209 (CUSIP Number) |
Ginkgo Bioworks Holdings, Inc. 27 Drydock Avenue, 8th Floor Boston, MA, 02210 8774225362 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
02/14/2025 (Date of Event Which Requires Filing of This Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
| CUSIP No. | 37611X209 |
| 1 |
Name of reporting person
Reshma P. Shetty | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
4,716,084.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
9.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person:
Rows 8, 10 and 11 consist of (i) 618,726 shares of Class A Common Stock of the Issuer and (ii) 4,097,358 shares of Class B Common Stock of the Issuer. Each share of Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder.
Row 13 is based on (i) 45,575,423 shares of Class A Common Stock outstanding as of December 31, 2024, based on information provided by the Issuer to Reporting Persons, (ii) 4,097,358 shares of Class A Common Stock issuable upon conversion of shares of Class B Common Stock.
SCHEDULE 13D
|
| CUSIP No. | 37611X209 |
| 1 |
Name of reporting person
Barry Canton | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
4,716,084.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
9.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person:
Rows 8, 10 and 11 consist of (i) 618,726 shares of Class A Common Stock of the Issuer and (ii) 4,097,358 shares of Class B Common Stock of the Issuer. Each share of Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder.
Row 13 is based on (i) 45,575,423 shares of Class A Common Stock outstanding as of December 31, 2024, based on information provided by the Issuer to Reporting Persons, (ii) 4,097,358 shares of Class A Common Stock issuable upon conversion of shares of Class B Common Stock.
This Amendment No. 4 (the "Amendment") amends and supplements the Schedule 13D filed by the Reporting Persons on September 27, 2021 and amended on October 1, 2022, January 24, 2023 and February 14, 2024 (the "Original Schedule 13D" and, as amended and supplemented by this Amendment, the "Schedule 13D") with respect to securities of the Issuer. Capitalized terms used in this Amendment and not otherwise defined shall have the same meanings ascribed to them in the Original Schedule 13D.
This Amendment updates the Original Schedule 13D to reflect a reverse stock split of the Issuer's Class A Common Stock, Class B Common Stock and Class C Common Stock at a ratio of one-for-forty (1:40), effected by the Issuer in August 2024. This Amendment also reflects an increase in the Issuer's number of shares of Class A Common Stock outstanding. The foregoing updates result in a decrease in the percentage of Class A Common Stock beneficially owned by the Reporting Persons.
SCHEDULE 13D
|
| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Class A Common Stock |
| (b) | Name of Issuer:
Ginkgo Bioworks Holdings, Inc. |
| (c) | Address of Issuer's Principal Executive Offices:
27 Drydock Avenue, 8th Floor, Boston,
MASSACHUSETTS
, 02210. |
| Item 5. | Interest in Securities of the Issuer |
| (a) | This Amendment amends and restates Item 5 of the Original Schedule 13D in its entirety:
The information included in Item 4 is incorporated herein by reference.
The following sets forth, as of the date of this Amendment, the aggregate number of shares of Class A Common Stock and percentage of Class A Common Stock beneficially owned by each of the Reporting Persons, as well as the number of shares of Class A Common Stock as to which each Reporting Person has the sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition of, or shared power to dispose or to direct the disposition of, as of the date hereof:
Reshma Shetty: Amount beneficially owned: 4,716,084; Percent of class: 9.5%; Sole power to vote or to direct the vote: 0; Shared power to vote or to direct the vote: 4,716,084; Sole power to dispose or to direct the disposition: 0; Shared power to dispose or to direct the disposition: 4,716,084
Barry Canton: Amount beneficially owned: 4,716,084; Percent of class: 9.5%; Sole power to vote or to direct the vote: 0; Shared power to vote or to direct the vote: 4,716,084; Sole power to dispose or to direct the disposition: 0; Shared power to dispose or to direct the disposition: 4,716,084 |
| (b) | The share amounts reflected in (a) above consist of the following: (i) 309,363 shares of Class A Common Stock and 58,005 shares of Class B Common Stock held of record by Ms. Shetty; (ii) 309,363 shares of Class A Common Stock and 58,005 shares of Class B Common Stock held of record by Mr. Canton; (iii) 1,754,744 shares of Class B Common Stock held of record by the Reshma Padmini Shetty Living Trust; (iv) 57,693 shares of Class B Common Stock held of record by Ms. Shetty's grantor retained annuity trust; (v) 1,749,744 shares of Class B Common Stock held of record by the Bartholomew Canton Living Trust; (vi) 57,693 shares of Class B Common Stock held of record by Mr. Canton's grantor retained annuity trust; (vii) 32,294 shares of Class B Common Stock held of record by The Asha S. Canton Irrevocable Trust and (viii) 32,294 shares of Class B Common Stock held of record by The Adhira S. Canton Irrevocable Trust. The Reporting Persons are married and may be deemed to share beneficial ownership over the shares held of record by each other and each of the foregoing trusts. Each share of Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder.
The percentages in (a) above are based on (i) 45,575,423 shares of Class A Common Stock outstanding as of December 31, 2024, based on information provided by the Issuer to Reporting Persons, (ii) 4,097,358 shares of Class A Common Stock issuable upon conversion of shares of Class B Common Stock. |
| (c) | Ms. Shetty has not effected any transactions in the Class A Common Stock during the past sixty days.
Mr. Canton has not effected any transactions in the Class A Common Stock during the past sixty days. |
| (d) | None. |
| (e) | Not applicable. |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|